1Amsden GW.Anti-inflammatory effects of macrolides-an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions? J Antimicrob Chemother,2005,55:10-21.
2Rubin BK,Henke MO.Immunomodulatory activity and effectiveness of macrolides in chronic airway disease.Chest,2004,125 (Suppl 2):S7-8.
6Sugihara E,Koyanagi T,Nizeki T,et al.Macrolide antibiotics directly reduces active oxygen generation by neutrophils in human peripheral blood.Kurume Med J,2003,50:9-15.
8Shinkai M,Tamaoki J,Kobayashi H,et al.Clarithromycin delays progression of bronchial epithelial cells from G1 phase to S phase and de-lays cell growth via extracellular signal-regulated protein kinase suppression.Antimicrob Agents Chemother,2006,5:1738-1744.
9Shinkai M,Lo'pez-Boado YS,Rubin BK.Clarithromycin has an immunomodulatory effect on ERK-mediated inflammation induced by Pseudomonas aeruginosa flagellin.J Antimicrob Chemother,2007,59:1096-1101.
10Asgrimsson V,Gudjonsson T,Gudmundsson GH,et al.Novel effects of azithromycin on tight junction proteins in human airway epitheha.Antimicrob Agents Chemother,2006,50:1805-1812.
5Lee SC, Brummet ME, Shahabuddin S, et al. Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes. J I mmunol, 2000,164 : 3392 -3401.
6Kadota J, Mukae H, Tomono K, et al. High concentrations of beta-chemokines in BAL fluid of patients with diffuse panbronchiolitis. Chest ,2001,120:602-607.
7Yanagihara K, Kadoto J, Kohno S. Diffuse panbronchiolitispathophysiology and treatment mechanisms. Int J Antimicrob Agents,2001,18(suppl 1) :S83-87.
8John E,Telmandge E, David A. Diffuse panbronchiolitis in the United States. Am J Respir Crit Care Mel, 1996,154:493.
9Krishnan P, Thachil R, Gillego V. Diffuse panbronchiolitis: a treatable sinobronchial disease in need of recognition in the United States. Chest, 2002,121: 659-661.
10Poletti V, Patelli M, Poletti G, et al. Diffuse panbronchiolitis observed in an Italian. Chest, 1990,98: 515.
6Amsden GW. Anti - inflammatory effects of macrolides-an underap-preciated benefit in the treatment of community-acquired respiratorytract infections and chronic inflammatory pulmonary conditions[ J] JAntimicrob Chemother, 2005,55 (1) : 10 - 21.
7Rubin BK,Henke MO. Immunomodulatory activity and effective-ness of macrolides in chronic airway disease[ J]. Chest, 2004, 125(2 Suppl) :70 -78.
8She J, Sun Q, Fan L, et al. Association of HLA genes with diffusepanbronchiolitis in Chinese patients [ J ]. Respir Physiol Neurobiol,2007, 157(2 -3):366 -373.
9Keicho N, Kudoh S. Diffuse panbronchiolitis: role of macrolides intherapy[ J]. Am J Respir Med, 2002, 1(2) ; 119 - 131.
10Sugihara E, Koyanagi T, Niizeki T, et al. Macrolide antibiotics di-rectly reduce active oxygen generation by neutrophils in human pe-ripheral blood[ J]. Kurume Med J,2003,50(1 -2) :9 - 15.
